序列剂量策略用于控制血催化中的选择性和血阶段贡献
1Department of Chemical and Biomolecular Engineering, University of Notre Dame, 250 Nieuwland Science Hall, Notre Dame, Indiana 46556, United States.
概括
本研究回顾了等离子体辅助催化剂,重点关注一种顺序方法,以了解催化剂作用. 这种方法有助于选择有效转化N2,CO2和SO2的催化剂.
科学领域:
- 化学工程是化学工程的重要组成部分.
- 材料科学 材料科学 材料科学
- 物理化学 物理化学
背景情况:
- 等离子体辅助催化使反应能够在环境条件下进行.
- 了解等离子体催化剂相互作用对于优化产品产量和选择性至关重要.
- 血和表面反应之间的复杂相互作用使催化剂选择复杂化.
研究的目的:
- 审查血和催化贡献脱的顺序方法.
- 提供对N2,CO2和SO2转化反应机制和催化剂行为的洞察.
- 建立一个框架,将这种方法应用于其他等离子体辅助反应.
主要方法:
- 使用顺序方法:非热等离子激活,然后进行催化转化.
- 检查涉及 (N2),二氧化碳 (CO2) 和二氧化硫 (SO2) 转换的研究.
- 在稳定状态或温度编程条件下分析反应机制和催化剂选择.
主要成果:
- 顺序方法有效地分离了等离子相和催化效应.
- 获得了对催化剂行为的洞察和对特定气体转换的选择.
- 开发了一个研究等离子体催化系统的系统框架.
结论:
- 序列方法提供了一个强大的工具,用于基本的理解等离子体催化.
- 这种方法可以指导各种反应的催化剂设计和过程优化.
- 进一步的研究应该探索这种方法的应用到更广泛的化学转化.
相关概念视频
Drug Concentration Versus Time Correlation
538
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
538
Drug Metabolism: Phase II Reactions
3.5K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.5K
Dosage Regimen: Fixed Dose
1.8K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.8K
Drug Distribution: Plasma Protein Binding
4.5K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
4.5K
Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview
30
Drug administration can occur through various routes, each of which may result in a different process of elimination. This process is often mixed with nonlinear and linear processes. It's important to understand that a single drug can be metabolized into different metabolites through parallel processes.
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...
30
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
52
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
52


